CYNTHIA G RIVAS PAJUELO
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism TUCSON, AZ NPI 1669967154
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism AZ SANOFI-AVENTIS U.S. LLC All categories
General Payments — all program years on this page
$2,864.45
- Category: General Payments
- Program years: PY2023–2024
- Record count: 99
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,823.45 across 73 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,812.16 | 72 |
| Education | $11.29 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $270.32 | 7 |
| Corcept Therapeutics | $212.45 | 5 |
| CeQur Corporation | $194.08 | 1 |
| Novo Nordisk AS | $152.80 | 10 |
| DEXCOM, INC. | $127.06 | 7 |
| MannKind Corporation | $103.95 | 5 |
| Radius Health, Inc. | $101.30 | 4 |
| Kyowa Kirin, Inc. | $85.59 | 3 |
| Amgen Inc. | $84.86 | 5 |
| Abbott Laboratories | $66.44 | 4 |
| Lilly USA, LLC | $57.39 | 3 |
| Medtronic, Inc. | $52.80 | 2 |
| BETA BIONICS, INC. | $51.22 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $42.79 | 3 |
| Xeris Pharmaceuticals, Inc. | $36.79 | 2 |
| Amphastar Pharmaceuticals, Inc. | $36.58 | 2 |
| Tandem Diabetes Care, Inc. | $29.21 | 1 |
| Ascendis Pharma Inc | $28.44 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $21.66 | 1 |
| Insulet Corporation | $20.00 | 1 |
| Ascensia Diabetes Care US Inc. | $18.11 | 1 |
| Amneal Pharmaceuticals LLC | $16.28 | 1 |
| TOLMAR, INC. | $13.33 | 1 |
By program year
Records — PY2024 (73)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.